Parkinson’s disease is a progressive neurological condition that affects movement, balance, and coordination. It is caused by the loss of dopamine-producing nerve cells in a part of the brain called the substantia nigra. Around 145,000 people in the UK are living with Parkinson’s, and approximately 18,000 new cases are diagnosed each year. Parkinson’s is the fastest-growing neurological condition in the world. It most commonly affects people over the age of 60, but around one in 20 people are diagnosed before the age of 50 — this is known as young-onset Parkinson’s.
While there is currently no cure, excellent treatments are available that can significantly improve quality of life and help people manage symptoms for many years. This guide covers everything you need to know about Parkinson’s disease, from early warning signs and NHS diagnosis to treatment, therapies, and support in the UK.
What Causes Parkinson’s Disease?
Parkinson’s disease occurs when nerve cells (neurons) in the substantia nigra — a small region deep in the brain — degenerate and die. These neurons are responsible for producing dopamine, a neurotransmitter that plays a vital role in coordinating smooth, controlled movement. As dopamine levels fall, the brain’s ability to control and coordinate movement becomes progressively impaired.
The exact reason neurons die in Parkinson’s is not fully understood. Abnormal clumps of a protein called alpha-synuclein (known as Lewy bodies) accumulate in the affected neurons and are a hallmark of the disease. The cause of Parkinson’s is thought to be a combination of genetic and environmental factors. Around 10–15% of cases have a genetic component, with mutations in genes such as LRRK2, SNCA, PINK1, and PARK2 identified. Environmental factors that may increase risk include exposure to certain pesticides and herbicides, repeated head injuries, and rural living. Interestingly, there is an inverse association with smoking and caffeine consumption, though these are not recommended as protective measures.
Early Warning Signs of Parkinson’s Disease
Parkinson’s often develops slowly, with subtle symptoms that can be easy to miss or attribute to normal ageing. Some early signs can appear years or even decades before the classic motor symptoms emerge. These may include:
- Loss of sense of smell (anosmia): One of the most common early signs, often preceding motor symptoms by years
- REM sleep behaviour disorder: Acting out vivid or violent dreams during sleep — a strong predictor of later Parkinson’s
- Constipation: The gut’s enteric nervous system is affected early in Parkinson’s
- Reduced facial expression: A subtle “masked” facial expression with less spontaneous blinking
- Small handwriting (micrographia): Writing that gradually becomes smaller and more cramped
- Soft or muffled voice: Reduced voice volume without obvious cause
- Slight tremor: A small tremor in a finger, hand, or foot, often noticed at rest
- Stiffness or slowness: Subtle difficulty with everyday movements, sometimes mistaken for arthritis
Symptoms of Parkinson’s Disease
Parkinson’s symptoms are classified as motor (movement-related) and non-motor. While the classic motor features define the condition, non-motor symptoms are often more debilitating and under-recognised.
Motor Symptoms
The three cardinal motor features of Parkinson’s disease are tremor, rigidity, and bradykinesia (slowness of movement). At least two of these must be present for a clinical diagnosis.
- Tremor: The most recognisable feature, typically starting in one hand at rest (a “pill-rolling” tremor). It often reduces during voluntary movement and disappears during sleep. Tremor is absent in around 30% of people with Parkinson’s.
- Rigidity: Muscle stiffness and resistance to movement, which can cause aching and a feeling of stiffness. Cogwheel rigidity — a ratchet-like resistance to passive movement — is characteristic.
- Bradykinesia: Slowness and reduced amplitude of movement, affecting everything from walking and getting dressed to facial expressions and swallowing.
- Postural instability: Impaired balance and righting reflexes, which typically develop later in the disease and significantly increase fall risk.
- Freezing: Sudden, temporary inability to initiate or continue movement — particularly walking — as if the feet are glued to the floor. This is a common cause of falls.
- Gait changes: Shuffling walk, reduced arm swing, festination (involuntary acceleration of steps), and difficulty turning.
Non-Motor Symptoms
Non-motor symptoms affect the vast majority of people with Parkinson’s and often have a greater impact on quality of life than motor features:
- Cognitive changes: Slowed thinking, difficulties with attention and executive function, and in later stages dementia (Parkinson’s disease dementia affects up to 80% of people with the condition over time)
- Depression and anxiety: Extremely common, affecting up to 40–50% of people, partly due to dopamine depletion itself
- Sleep disturbances: Insomnia, REM sleep behaviour disorder, excessive daytime sleepiness, and restless legs syndrome
- Autonomic dysfunction: Orthostatic hypotension (dizziness on standing), constipation, urinary urgency, excessive sweating, and sexual dysfunction
- Pain: Musculoskeletal pain, dystonia-related cramping, and neuropathic pain
- Fatigue: Profound and common, not necessarily linked to sleep quality
- Swallowing difficulties (dysphagia): Can lead to aspiration pneumonia — a leading cause of death in advanced Parkinson’s
- Drooling (sialorrhoea): Due to reduced automatic swallowing rather than excess saliva production
- Hallucinations and psychosis: Often medication-related, particularly in later stages
- Skin changes: Oily or flaky skin (seborrhoeic dermatitis) is common
Diagnosing Parkinson’s Disease
There is no definitive blood test or scan that can confirm Parkinson’s. Diagnosis is clinical — based on the medical history, observation of symptoms, and neurological examination. NICE guidelines recommend referral to a specialist (typically a neurologist or geriatrician with expertise in movement disorders) for anyone suspected of having Parkinson’s. A diagnosis should not be made solely by a GP.
The UK Brain Bank Criteria are widely used as the diagnostic standard. They require the presence of bradykinesia plus either tremor or rigidity, along with supportive features and the absence of exclusion criteria (such as a history of strokes, early severe dementia, or exposure to dopamine-blocking drugs). A good response to levodopa therapy is a strong supportive feature of Parkinson’s diagnosis.
Brain imaging (MRI or CT) may be performed to exclude other causes of parkinsonism. DaTscan (DAT-SPECT) is a nuclear medicine scan that can visualise dopamine transporter activity in the brain and help distinguish Parkinson’s from essential tremor, though it cannot differentiate Parkinson’s from other forms of parkinsonism.
Parkinson’s vs Parkinsonism
Parkinson’s disease is the most common cause of parkinsonism (a set of movement features including tremor, rigidity, and bradykinesia), accounting for around 75% of cases. Other conditions can cause parkinsonism and may be mistaken for Parkinson’s. These include multiple system atrophy (MSA), progressive supranuclear palsy (PSP), dementia with Lewy bodies (DLB), corticobasal syndrome, and drug-induced parkinsonism (caused by antipsychotics, metoclopramide, and other dopamine-blocking medications).
NHS Treatment for Parkinson’s Disease
Parkinson’s is managed by a multidisciplinary team, typically including a neurologist or geriatrician, Parkinson’s specialist nurse, physiotherapist, occupational therapist, and speech and language therapist. Treatment focuses on managing symptoms, maintaining quality of life, and slowing functional decline. All medications used in Parkinson’s work by increasing or mimicking dopamine in the brain.
Levodopa
Levodopa remains the gold-standard treatment for Parkinson’s and is the most effective medication available. It is converted to dopamine in the brain, directly replacing what is lost. In the UK, levodopa is always combined with a decarboxylase inhibitor — either carbidopa (as co-careldopa / Sinemet) or benserazide (as co-beneldopa / Madopar) — to prevent it being converted to dopamine before it reaches the brain, thereby reducing side effects.
After several years of levodopa therapy, many people develop motor fluctuations — periods when medication is working well (“on” time) alternating with periods when it wears off and symptoms return (“off” time) — as well as dyskinesias (involuntary writhing movements) at peak medication levels. Managing these fluctuations is one of the central challenges of long-term Parkinson’s care.
Dopamine Agonists
Dopamine agonists mimic the action of dopamine in the brain and include ropinirole, pramipexole (both oral), and rotigotine (a once-daily patch). They are often used as initial treatment in younger patients or as adjuncts to levodopa. Impulse control disorders — including compulsive gambling, hypersexuality, binge eating, and compulsive spending — are a significant side effect associated with dopamine agonists and affect around 10–15% of users.
MAO-B Inhibitors and Other Agents
Selegiline and rasagiline are MAO-B (monoamine oxidase-B) inhibitors that slow the breakdown of dopamine in the brain. They can be used as monotherapy in early disease or added to levodopa to reduce motor fluctuations. Entacapone (a COMT inhibitor) prolongs the effect of each levodopa dose by preventing its breakdown. Amantadine is used for dyskinesias and can also have modest anti-parkinsonian effects.
Deep Brain Stimulation (DBS)
Deep brain stimulation is a surgical procedure involving implantation of electrodes into targeted brain regions (typically the subthalamic nucleus or globus pallidus). The electrodes deliver continuous electrical pulses that modulate abnormal brain activity. DBS is highly effective for appropriately selected patients — particularly those with significant motor fluctuations or dyskinesias who respond well to levodopa. It is available on the NHS through specialist neurosurgical centres. DBS does not cure Parkinson’s or slow progression, but it can dramatically reduce “off” time and dyskinesias.
Advanced Therapies
For people with advanced Parkinson’s who experience difficult motor fluctuations, NHS advanced therapies include continuous subcutaneous apomorphine infusion (a dopamine agonist delivered via a pump under the skin) and continuous intestinal levodopa-carbidopa gel infusion (Duodopa), delivered directly into the small intestine via a PEG tube. These provide more stable dopamine delivery and reduce fluctuations. Focused ultrasound thalamotomy is a newer non-invasive procedure available at some NHS centres for tremor-dominant Parkinson’s.
Physiotherapy, Occupational Therapy, and Speech Therapy
Allied health therapies are essential in Parkinson’s care. Physiotherapy can address balance, gait, freezing, and exercise capacity — exercise has strong evidence for slowing motor decline and improving quality of life. The LSVT BIG programme is a physiotherapy intervention specifically designed for Parkinson’s that focuses on amplitude and intensity of movement. Occupational therapy helps maintain independence with daily tasks, aids and adaptations, and fall prevention. Speech and language therapy (SALT) addresses voice, communication, and swallowing. The LSVT LOUD programme focuses on voice volume and clarity. Dietetic input is also important, particularly regarding protein intake timing around levodopa doses.
Living with Parkinson’s Disease
Living with Parkinson’s presents daily challenges, but many people manage the condition well for many years, particularly with early diagnosis and comprehensive care. Regular exercise is one of the most evidence-based interventions for maintaining function — boxing, dancing, swimming, cycling, and yoga have all shown benefits. The Parkinson’s UK charity (0808 800 0303) provides extensive support, information, a helpline, and local support groups across the UK.
Medication timing is crucial in Parkinson’s. Missing doses or taking them late can have significant consequences. Hospital admission can be particularly risky if medication is not given on time — Parkinson’s UK’s “Get it on time” campaign promotes awareness of this among NHS staff. People with Parkinson’s are advised to carry a medication alert card and to discuss emergency medication needs with their care team.
PIP (Personal Independence Payment) and Attendance Allowance may be available. A blue badge may help with parking. Many people with Parkinson’s continue working for years after diagnosis, often with adjustments. The DVLA must be informed of a Parkinson’s diagnosis, as driving may need to be reviewed.
Key Takeaways
- Parkinson’s disease affects around 145,000 people in the UK and is caused by loss of dopamine-producing neurons in the brain
- Early warning signs — including loss of smell, constipation, and REM sleep disorder — can precede motor symptoms by years
- The three cardinal motor features are tremor, rigidity, and bradykinesia (slowness); non-motor symptoms are often equally or more disabling
- Diagnosis is clinical and should be made by a specialist — there is no definitive blood test
- Levodopa (combined with carbidopa or benserazide) is the most effective medication available
- Deep brain stimulation is an effective surgical option for selected patients with advanced motor fluctuations
- Exercise, physiotherapy, speech therapy, and occupational therapy are essential parts of care alongside medication
- Parkinson’s UK (0808 800 0303) offers free information, helpline support, and local groups across the UK
Related Health Guides on YourHealthXpert
Explore these related NHS-aligned health guides:
- Dementia & Alzheimer’s Guide — Parkinson’s dementia affects up to 80% of patients over time; learn how NHS memory services support Parkinson’s patients experiencing cognitive decline.
- Multiple Sclerosis Guide — Both MS and Parkinson’s are progressive neurological conditions managed through NHS neurology; understand the differences in mechanism and treatment approach.
- Anxiety & Depression Guide — Depression affects over half of Parkinson’s patients and is part of the condition, not just a reaction to it; learn about NHS neuropsychiatric support.
- Osteoporosis Guide — Parkinson’s significantly increases fall and fracture risk through balance and gait problems; learn about NHS bone health strategies and fall prevention.
- High Blood Pressure Guide — Orthostatic hypotension (sudden blood pressure drops) is common in Parkinson’s; understand the NHS approach to managing blood pressure in Parkinson’s.
- Stroke Guide — Parkinson’s and stroke can be difficult to distinguish acutely; understand the FAST signs and NHS emergency pathways, and how stroke can sometimes trigger parkinsonism.